Transdiaphragmatic Mucormycosis

descriptionPublicationkeyboard_double_arrow_right Article 19 Jun 2019 English Publisher:Oxford University Press (OUP)Journal:Clinical Infectious Diseases, volume 70, pages 940-942 (issn: 1058-4838, eissn: 1537-6591,

Authors: Philipp Koehler; Robert Reimer; Roger Wahba; Birgid Schömig-Markiefka; Oliver A Cornely;

doi: 10.1093/cid/ciz533

pmid: 31222210

Transdiaphragmatic Mucormycosis

- Summary
- Subjects
- Metrics

Abstract

Abstract Mucormycosis is a life-threatening infection. This is the first report of transdiaphragmatic mucormycosis in a series of 3 patients. We observed this phenomenon in 11% of patients. Clinicians should be aware of this possibly underreported entity, and as a consequence we envision more comprehensive imaging studies in patients with mucormycosis.

Related Organizations

German Center for Infection Research
Germany
Ludwig-Maximilians-Universität München
Germany
Pathologisches Institut
Germany
Deutsche Zentren der Gesundheitsforschung
Germany
University of Cologne
Germany

View all View all

Keywords

Antifungal Agents, Humans, Mucormycosis, Triazoles

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average